Wolfgang Wick
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Biological Psychiatry top 0.1%
Papers in
- Genetics 419
- Glioma Diagnosis and Treatment 410
-
- Brain Metastases and Treatment 127
- Co-authors
- Michael Weller (206 shared papers)Michael Platten (145 shared papers)Roger Stupp (42 shared papers)Andreas von Deimling (100 shared papers)Guido Reifenberger (43 shared papers)Martin Bendszus (158 shared papers)Martin J. van den Bent (70 shared papers)Timothy F. Cloughesy (41 shared papers)
- Journals
- Neuro-Oncology (115 papers)Journal of Clinical Oncology (74 papers)Journal of Neuro-Oncology (21 papers)Neuro-Oncology Advances (19 papers)Acta Neuropathologica (18 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Wolfgang Wick
600 papers receiving 41.6k citations
Wolfgang Wick's Hit Papers
Peers
Comparison fields: 5 of 207
- Genetics 22.2k
- Biological Psychiatry 1.7k
- Cancer Research 8.0k
- Radiology, Nuclear Medicine and Imaging 8.9k
- Oncology 7.5k
Countries citing papers authored by Wolfgang Wick
This map shows the geographic impact of Wolfgang Wick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Wick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Wick more than expected).
Fields of papers citing papers by Wolfgang Wick
This network shows the impact of papers produced by Wolfgang Wick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Wick. The network helps show where Wolfgang Wick may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolfgang Wick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 631 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Hit paper breakdown → | 2010 | 2726 |
| 2 | Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma Hit paper breakdown → | 2014 | 1825 |
| 3 | An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Hit paper breakdown → | 2011 | 1443 |
| 4 | Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas Hit paper breakdown → | 2009 | 868 |
| 5 | Glioma Hit paper breakdown → | 2015 | 792 |
| 6 | Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial Hit paper breakdown → | 2012 | 769 |
| 7 | Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity Hit paper breakdown → | 2008 | 658 |
| 8 | How to use and assess qualitative research methods Hit paper breakdown → | 2020 | 633 |
| 9 | Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas Hit paper breakdown → | 2010 | 627 |
| 10 | Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo Hit paper breakdown → | 2002 | 605 |
| 11 | Standards of care for treatment of recurrent glioblastoma—are we there yet? Hit paper breakdown → | 2012 | 587 |
| 12 | MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Hit paper breakdown → | 2009 | 575 |
| 13 | NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide Hit paper breakdown → | 2009 | 571 |
| 14 | EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma Hit paper breakdown → | 2014 | 568 |
| 15 | Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma Hit paper breakdown → | 2008 | 566 |
| 16 | Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2022 | 565 |
| 17 | Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion Hit paper breakdown → | 2012 | 554 |
| 18 | Immunotherapy response assessment in neuro-oncology: a report of the RANO working group Hit paper breakdown → | 2015 | 471 |
| 19 | Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma Hit paper breakdown → | 2014 | 445 |
| 20 | Gadolinium Retention in the Dentate Nucleus and Globus Pallidus Is Dependent on the Class of Contrast Agent Hit paper breakdown → | 2015 | 432 |
About Wolfgang Wick
Wolfgang Wick is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 631 papers that have together received 42.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (410 papers), Brain Metastases and Treatment (127 papers), Radiomics and Machine Learning in Medical Imaging (66 papers), MRI in cancer diagnosis (52 papers), Meningioma and schwannoma management (48 papers), Cancer, Hypoxia, and Metabolism (46 papers), Epigenetics and DNA Methylation (40 papers) and Advanced MRI Techniques and Applications (40 papers). The work is most often cited by research in Genetics (22.2k citations), Biological Psychiatry (1.7k citations), Cancer Research (8.0k citations), Radiology, Nuclear Medicine and Imaging (8.9k citations) and Oncology (7.5k citations). Wolfgang Wick has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Michael Weller, Michael Platten, Roger Stupp, Andreas von Deimling, Guido Reifenberger, Martin Bendszus, Martin J. van den Bent, Timothy F. Cloughesy, Alexander Radbruch and Felix Sahm. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Journal of Neuro-Oncology, Neuro-Oncology Advances and Acta Neuropathologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.